SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo
Authors
Keywords
Hepatocellular carcinoma, Chemotherapy, Polymersome, Reduction-responsivity, Liver targeting
Journal
COLLOIDS AND SURFACES B-BIOINTERFACES
Volume 197, Issue -, Pages 111399
Publisher
Elsevier BV
Online
2020-10-06
DOI
10.1016/j.colsurfb.2020.111399
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SP94-Targeted Triblock Copolymer Nanoparticle Delivers Thymidine Kinase–p53–Nitroreductase Triple Therapeutic Gene and Restores Anticancer Function against Hepatocellular Carcinoma in Vivo
- (2020) Uday K. Sukumar et al. ACS Applied Materials & Interfaces
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo
- (2019) Yaohua Wei et al. Acta Biomaterialia
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- CD44‐Specific A6 Short Peptide Boosts Targetability and Anticancer Efficacy of Polymersomal Epirubicin to Orthotopic Human Multiple Myeloma
- (2019) Wenxing Gu et al. ADVANCED MATERIALS
- Organocatalytic Ring-Opening Copolymerization of Trimethylene Carbonate and Dithiolane Trimethylene Carbonate: Impact of Organocatalysts on Copolymerization Kinetics and Copolymer Microstructures
- (2018) Jingjing Wei et al. BIOMACROMOLECULES
- Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review
- (2018) Mohammad Mohajeri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Recent trends of nanomedicinal approaches in clinics
- (2018) Fahima Dilnawaz et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Glycyrrhetinic Acid-Modified Norcantharidin Nanoparticles for Active Targeted Therapy of Hepatocellular Carcinoma
- (2018) Heng Zhang et al. Journal of Biomedical Nanotechnology
- Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
- (2018) Lisa Belfiore et al. JOURNAL OF CONTROLLED RELEASE
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- A novel galactose-PEG-conjugated biodegradable copolymer is an efficient gene delivery vector for immunotherapy of hepatocellular carcinoma
- (2018) Ling Liu et al. BIOMATERIALS
- Dual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma
- (2018) Mona A. Abdelmoneem et al. JOURNAL OF CONTROLLED RELEASE
- Cancer nanomedicine: mechanisms, obstacles and strategies
- (2018) Huafei Li et al. Nanomedicine
- Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis
- (2017) Richard S. Finn et al. HEPATOLOGY
- Nanoparticles and targeted drug delivery in cancer therapy
- (2017) Behdokht Bahrami et al. IMMUNOLOGY LETTERS
- ATN-161 Peptide Functionalized Reversibly Cross-Linked Polymersomes Mediate Targeted Doxorubicin Delivery into Melanoma-Bearing C57BL/6 Mice
- (2017) Ning Zhang et al. MOLECULAR PHARMACEUTICS
- Folic-Acid-Mediated Functionalized Gold Nanocages for Targeted Delivery of Anti-miR-181b in Combination of Gene Therapy and Photothermal Therapy against Hepatocellular Carcinoma
- (2016) Shengnan Huang et al. ADVANCED FUNCTIONAL MATERIALS
- Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
- (2016) Roberto Marques Damiani et al. ARCHIVES OF TOXICOLOGY
- Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin
- (2016) Xiaoran Zhang et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Nanomedicine in management of hepatocellular carcinoma: Challenges and opportunities
- (2016) Nourhan K. Mohamed et al. INTERNATIONAL JOURNAL OF CANCER
- Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
- (2016) Min Li et al. International Journal of Nanomedicine
- Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx?
- (2016) Yan Zou et al. JOURNAL OF CONTROLLED RELEASE
- Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy
- (2016) Yuee Cai et al. MOLECULAR PHARMACEUTICS
- Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
- (2016) Marco Demaria et al. Cancer Discovery
- Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma
- (2016) Le Chang et al. Oncotarget
- Investigation of SP94 Peptide as a Specific Probe for Hepatocellular Carcinoma Imaging and Therapy
- (2016) Yanli Li et al. Scientific Reports
- pH-Sensitive Pt Nanocluster Assembly Overcomes Cisplatin Resistance and Heterogeneous Stemness of Hepatocellular Carcinoma
- (2016) Hongping Xia et al. ACS Central Science
- Variable asialoglycoprotein receptor 1 expression in liver disease: Implications for therapeutic intervention
- (2015) Dominik Witzigmann et al. HEPATOLOGY RESEARCH
- Improved Peptide-Targeted Liposome Design Through Optimized Peptide Hydrophilicity, Ethylene Glycol Linker Length, and Peptide Density
- (2015) Jared F. Stefanick et al. Journal of Biomedical Nanotechnology
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- Emerging trends in hepatocellular carcinoma incidence and mortality
- (2014) Basile Njei et al. HEPATOLOGY
- Transferrin targeted core-shell nanomedicine for combinatorial delivery of doxorubicin and sorafenib against hepatocellular carcinoma
- (2014) Giridharan Loghanathan Malarvizhi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Functionalization of protein-based nanocages for drug delivery applications
- (2014) Lise Schoonen et al. Nanoscale
- A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells
- (2013) Riki Toita et al. CHEMICAL COMMUNICATIONS
- Targeting Hepatic Cancer Cells with PEGylated Dendrimers DisplayingN-Acetylgalactosamine and SP94 Peptide Ligands
- (2013) Scott H. Medina et al. Advanced Healthcare Materials
- Delivery of Ricin Toxin A-Chain by Peptide-Targeted Mesoporous Silica Nanoparticle-Supported Lipid Bilayers
- (2012) Katharine Epler et al. Advanced Healthcare Materials
- Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like Particles
- (2011) Carlee E. Ashley et al. ACS Nano
- The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers
- (2011) Carlee E. Ashley et al. NATURE MATERIALS
- Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy
- (2010) Chao Wang et al. BIOMATERIALS
- pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: A comparative study with micelles
- (2009) Wei Chen et al. JOURNAL OF CONTROLLED RELEASE
- Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery
- (2008) A. Lo et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started